- Zenflow secures $52M Series D financing to support commercialization of its Spring System
Zenflow secures $52M Series D financing to support commercialization of its Spring System
- InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
- Purple AI closes Series A, doubles valuation as it targets US stroke AI market
Purple AI closes Series A, doubles valuation as it targets US stroke AI market
- Masimo receives CE Mark for AI-Powered smartSedLine Brain Function monitor to advance anesthetic management
Masimo has received CE Mark approval for smart SedLine, its next-generation brain function monitor designed to improve intraoperative anesthesia management. The key innovation is an AI-powered Patient State Index (PSi) algorithm, which continuously processes bilateral frontal EEG data and translates
- Wellvii BP Go achieves FDA clearance as a compact, non-invasive blood pressure finger cuff
Wellvii announced FDA clearance for its BP Go blood pressure monitor, which uses a finger-based sensor to measure blood pressure rather than the traditional inflatable arm cuff, and is designed for home and remote-care monitoring settings. BP Go runs on the same finger-based NIBP algorithm as Wellvi
- VB Spine completes acquisition of Augmedics' CT-to-fluoroscopy navigation technology
VB Spine has completed its acquisition of exclusive rights to Augmedics' CT-to-fluoroscopy technology for spine applications and plans to integrate it into its xvision Spine System platform. The deal builds on VB Spine's April acquisition of exclusive rights to the xvision platform itself, also from
- OncoSil wins FDA humanitarian exemption for bile duct cancer device
The FDA has granted OncoSil Medical a humanitarian device exemption for its OncoSil system to treat distal cholangiocarcinoma, a rare bile duct cancer. The Australian company's device delivers targeted beta radiation directly into tumors via endoscopic ultrasound-guided injection, aiming to destroy
- GS MedTech Funding Tracker – Bridge to Life, Flagler, and more
From organ preservation and AI-powered MSK care to autonomous imaging, respiratory monitoring and ultrasound BCI, this week’s MedTech funding activity highlights strong investor interest in technologies targeting clinical efficiency, earlier diagnosis and more accessible care. Read more below. As an
- Noah Medical launches next-gen software for robotic-assisted bronchoscopy
Noah Medical has launched Galaxy II, updated software for its Galaxy robotic-assisted bronchoscopy platform used to biopsy small, hard-to-reach lung lesions. The system's core feature is Dual-Mode Imaging, letting physicians switch between High-Definition Digital Tomosynthesis and Cone-Beam CT mid-p
- Calidar closes first-in-human study of 4D mammography device, advances toward 2027 pivotal trial
Calidar has closed out its first-in-human study of the Eidos Prism, a device that adds Volumetric X-Ray Diffraction, marketed as 4D Mammography, to existing 3D mammography systems. The study enrolled 61 patients at Baptist Health Hardin in Elizabethtown, Kentucky. Two manuscripts covering the device
- Bridge to Life raises $110M to scale VitaSmart perfusion system across US transplant centers
Bridge to Life has closed $110 million in Series C equity and debt financing, led by new investor Soleus Capital alongside Lauxera Capital Partners and participation from company directors, officers, and employees. Soleus Capital Credit Opportunities Fund provided the debt portion. The funds will ex
- Versa Vascular expands Series C to $42M, names new CEO
Versa Vascular has expanded its Series C financing by $15 million, bringing total committed capital for the round to $42 million. The Santa Cruz-based company develops a transcatheter tricuspid repair device called AdapTR, and the new funding will support an ongoing first-in-human study outside the
Market Insight
Evidence-Based Deep Dive
Top Picks
Latest MedTech News
Masimo has received CE Mark approval for smartSedLine, its next-generation brain function monitor designed to improve intraoperative anesthesia management. The key innovation is an AI-powered Patient State Index (PSi) algorithm, which continuously processes bilateral frontal EEG data and translates
Wellvii announced FDA clearance for its BP Go blood pressure monitor, which uses a finger-based sensor to measure blood pressure rather than the traditional inflatable arm cuff, and is designed for home and remote-care monitoring settings.
BP Go runs on the same finger-based NIBP algorithm as Wellvii
VB Spine has completed its acquisition of exclusive rights to Augmedics' CT-to-fluoroscopy technology for spine applications and plans to integrate it into its xvision Spine System platform. The deal builds on VB Spine's April acquisition of exclusive rights to the xvision platform itself, also from
The FDA has granted OncoSil Medical a humanitarian device exemption for its OncoSil system to treat distal cholangiocarcinoma, a rare bile duct cancer. The Australian company's device delivers targeted beta radiation directly into tumors via endoscopic ultrasound-guided injection, aiming to destroy
From organ preservation and AI-powered MSK care to autonomous imaging, respiratory monitoring and ultrasound BCI, this week’s MedTech funding activity highlights strong investor interest in technologies targeting clinical efficiency, earlier diagnosis and more accessible care. Read more below.
As an
Noah Medical has launched Galaxy II, updated software for its Galaxy robotic-assisted bronchoscopy platform used to biopsy small, hard-to-reach lung lesions. The system's core feature is Dual-Mode Imaging, letting physicians switch between High-Definition Digital Tomosynthesis and Cone-Beam CT mid-p
Calidar has closed out its first-in-human study of the Eidos Prism, a device that adds Volumetric X-Ray Diffraction, marketed as 4D Mammography, to existing 3D mammography systems. The study enrolled 61 patients at Baptist Health Hardin in Elizabethtown, Kentucky. Two manuscripts covering the device
Bridge to Life has closed $110 million in Series C equity and debt financing, led by new investor Soleus Capital alongside Lauxera Capital Partners and participation from company directors, officers, and employees. Soleus Capital Credit Opportunities Fund provided the debt portion. The funds will ex
Versa Vascular has expanded its Series C financing by $15 million, bringing total committed capital for the round to $42 million. The Santa Cruz-based company develops a transcatheter tricuspid repair device called AdapTR, and the new funding will support an ongoing first-in-human study outside the